Joint Planning in Paediatric Rehabilitation

July 13, 2022 updated by: Laura Brunton, Western University, Canada

The Effectiveness of Joint Planning in Paediatric Rehabilitation: Parent and Child Related Outcomes

We will use one group, pretest-posttest research design. The intervention will have a 6-month timeframe. Up to 18 participants will be selected from active caseloads of the three to six participating healthcare providers in the Early Childhood Rehabilitation Program at the Alberta Children's Hospital, Child Development Centre site in Calgary Alberta. All data will be collected in Alberta using remote measures. Parents and therapists will complete surveys in an online portal. One measure needs to be completed in conjunction with the therapist and parent and will be done in person using an online portal. The researchers will have a local investigator (Debra Teitelbaum) in Calgary who works on-site to help manage data collection and recruitment in person if necessary.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Calgary, Alberta, Canada, T3B6A8
        • Alberta Children's Hospital - Early Childhood Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Receiving care for developmental delay

Exclusion Criteria:

  • Cannot speak or read english

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Canadian Occupational Performance Measure (COPM)
Time Frame: Change in COPM performance and satisfaction between baseline and 6-months.
An evidence-based measure designed to capture a client's/familie's self-perception of performance in everyday living, their satisfaction with their performance, and changes in performance/satisfaction over time. It is one method of setting and measuring achievement of individualized therapeutic goals.
Change in COPM performance and satisfaction between baseline and 6-months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of Processes of Care (MPOC)
Time Frame: Change in MPOC (satisfaction) between baseline and 6-months.
Satisfaction with healthcare services - the MPOC is a self-report measure of parents' perceptions of the extent to which the health services they and their child(ren) receive are family-centred.
Change in MPOC (satisfaction) between baseline and 6-months.
PedsQL Family Impact Module
Time Frame: Change in PedsQL Family Impact Module between baseline and 6-months
Quality of life
Change in PedsQL Family Impact Module between baseline and 6-months
Parent Stress Index
Time Frame: Change in Parenting Stress Index between baseline and 6-months
Stress
Change in Parenting Stress Index between baseline and 6-months
Self-efficacy Visual Analog Scale
Time Frame: Change in self-efficacy between baseline and 6-months
self efficacy rating of ability to carry out home exercises, 0-100mm line, higher equals more self-efficacy
Change in self-efficacy between baseline and 6-months
Therapist perceived parent efficacy Visual Analog Scale
Time Frame: Change in efficacy between baseline and 6-months
Therapist rated parent efficacy rating of ability to carry out home exercises, 0-100mm line, higher equals more efficacy
Change in efficacy between baseline and 6-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laura K Brunton, PhD, Western University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2020

Primary Completion (Anticipated)

August 1, 2022

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

May 6, 2020

First Submitted That Met QC Criteria

May 8, 2020

First Posted (Actual)

May 13, 2020

Study Record Updates

Last Update Posted (Actual)

July 18, 2022

Last Update Submitted That Met QC Criteria

July 13, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 115539

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Individual participant data can be requested from the PI and all requests will be considered on an individual basis

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children With Developmental Delay

Clinical Trials on Applied Coaching Model

3
Subscribe